Continuing Education Opportunities on the Web

Published: Tuesday, Mar 09, 2010
Click here to view as a PDF.

Breast Cancer –

SABCS*


Mixed results for targeted agents in breast cancer

Credits: 0.25

Fee: None

Expires: December 13, 2010

This activity reviews the results of several studies presented at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS) that assessed targeted therapy plus chemotherapy in patients with advanced breast cancer; these studies yielded mixed results. Upon reading the article, participants must correctly answer two multiple-choice questions to receive credit.

http://tinyurl.com/y96s8p5

Benefits of bevacizumab modest in metastatic disease

Credits:
0.25

Fee:
None

Expires:
December 15, 2010

This activity reviews two studies presented at SABCS that showed only a limited increase in survival when bevacizumab was added to a chemotherapy regimen for patients with metastatic breast cancer. Upon reading the article, participants must correctly answer two multiple-choice questions to receive credit.

http://tinyurl.com/y9rtcpb

HER2 combo boosts metastatic breast cancer survival


Credits: 0.25

Fee: None

Expires: December 15, 2010

This activity is based on a study presented at SABCS that shows that a dual biologic attack on heavily pretreated metastatic breast cancer with lapatinib and trastuzumab may substantially prolong survival, without chemotherapy or endocrine therapy. Upon reading the article, participants must correctly answer two multiple-choice questions to receive credit.

www.medpagetoday.com/MeetingCoverage/ SABCS/17536

Vitamin D reduces aromatase inhibitor pain


Credits:
0.25

Fee:
None

Expires: December 15, 2010

This activity is based on a study presented at the 2009 American Society of Hematology (ASH) annual meeting that indicated that a highdose of vitamin D might relieve musculoskeletal pain caused by treatment of breast cancer with aromatase inhibitors. Upon reading the article, participants must correctly answer two multiple-choice questions to receive credit.

http://tinyurl.com/y8p3j7j

*More SABCS CME opportunities are available at medpage Today at www.medpagetoday.com/ MeetingCoverage/SABCS.






Colorectal Cancer




Surgical approach to liver-limited metastatic colorectal cancer

Credits: 1.5

Fee: None

Expires: September 15, 2010

Multimedia: Yes

Participants are required to read an E-Update in which experts write about recent liver-limited colon cancer advances. The update discusses biologic, surgical, and toxicity issues in liver-limited disease. Successful completion of a posttest with a passing score of 80% or better earns the participant the credits. The activity in its entirety should take approximately 2 hours to complete. http://tinyurl.com/yae5rj6




Kidney Cancer


Management of small renal masses: What is the best management option in this case?

Credits: 1

Fee: None

Expiration: January 21, 2010

Multimedia: Webcast

At the conclusion of this activity, participant will be able to contrast the benefits and pitfalls of specific management options for patients that present with an incidental renal mass, including radical nephrectomy, partial nephrectomy, energy ablation, and active surveillance; discuss the potential morbidity associated with active surveillance strategies, including the risk of local and metastatic progression; and explain issues of patient selection for appropriate management for a small renal mass.

http://tinyurl.com/ye8g6w5

Innovations and challenges in renal cancer

Credits: 2

Fee: None

Expiration: May 2010

Multimedia: None

Following completion of this activity, participants should be able to discuss how recognized molecular targets in renal cancer are related to prognosis and current and future therapeutic approaches; discuss current approaches to prognostic classification in renal cancer as they relate to treatment selection and expectation; and assess recent clinical data for immunotherapies and targeted and anti-angiogenic therapies in renal cancer treatment.

http://tinyurl.com/y8co2u5




Lung Cancer

Management of stage III, N2 NSCLC: A virtual thoracic oncology tumor board

Credits: 1.50

Fee: None

Expires: June 30, 2010


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Bridging the Gaps Around Oncology Biosimilars: Assessing the Potential Impact of Emerging Agents to PracticeSep 29, 20181.5
Community Practice Connections: Oncology Best Practice™ Targeting Cell Cycle Progression: The Latest Advances on CDK4/6 Inhibition in Metastatic Breast CancerOct 31, 20181.0
Publication Bottom Border
Border Publication
x